直 Japanese PDF Font
  • 我们的专业人员
  • 服务
  • 我们的见解
  • 办公室
  • 事务所
  • 人才招聘
Finnegan
    • AI + Finnegan
    • Appeals, Issues, and Legal Strategy
    • Diligence, Licensing, and Opinions
    • Global IP Enforcement, Litigation, and Trials
    • Patent Office Invalidation Proceedings
    • Prosecution and Portfolio Management
    • Trademark and Brand Management
    • AI, Electronics, and Information Technology
    • Chemicals, Industrials, and Materials
    • Communications
    • Consumer Goods and Services
    • Energy
    • Hospitality, Gaming, and Leisure
    • 生命科学
    • Transportation and Logistics
  • 经验

上诉、争议和法律策略

About

知识产权上诉需要对细节一丝不苟。这需要律师对法律和事实有透彻的了解,以找出最有希望的一两个关键论据来说服上诉法官专家组。飞翰以高质量的辩护书和口头辩论著称。我们深知上诉过程一般在实际提出上诉之前就已经开始。我们的上诉律师兼具创造性的法律思维和熟练的写作手法,他们与庭审团队合作,制定法律策略,撰写能获胜的简报,并合理地维护上诉争议。

在欧洲、德国、英国和美国等地的上诉经验

我们的成功不仅源于我们独特的技术专长,也源于我们在欧洲、德国、英国和美国法院的丰富上诉经验。飞翰律师在联邦巡回上诉法院陈述和申辩的案件数达百余件,远超任何其他律所。约有40多名律师曾在联邦巡回上诉法院或其前身法院担任法官助理职务。在最高法院,飞翰既能代理上诉人,也能代理被上诉人,并在移审阶段和案情审理阶段协助法院之友提交案情陈述。我所律师参加过50多起案件的案情陈述,也在最高法院申辩了多起案件,其中包括Bilski诉Kappos和Bonito Boats诉Thunder Craft Boats等标志性案件。无论是在美国最高法院还是在德国联邦法院,我们的律师都深知上诉的利害关系,并将制定战略来满足客户需求。

合作推进商业目标、提升市场价值

保护和促进创新及市场信任是飞翰的基本宗旨。飞翰坚持具有服务精神的文化且保持在专业律师协会和法律协会的领导地位,并与工业界同仁和政府合作以促进知识产权保护和提高行业专业水准。我们参与的组织包括联邦律师协会(FBA)、联邦巡回法院律师协会(FCBA)、美国知识产权法协会(AIPLA)、知识产权所有者协会(IPO)。

Everyone in this practice

业务范围

Appeals from the PTAB

Patent Trial and Appeal Board (PTAB) decisions are appealed directly to the US Court of Appeals for the Federal Circuit, where Finnegan attorneys have briefed and argued hundreds of cases.

View Appeals from the PTAB

联邦巡回法院和最高法院上诉

上诉需要细致入微地关注相关细节,要求律师对上诉法有透彻的了解,以找出最有希望的一两个关键论据并加以利用。

View 联邦巡回法院和最高法院上诉

欧洲专利异议和上诉

欧洲专利局(EPO)的异议程序为第三方提供了在欧洲专利授权后的一段有限的时间内,在欧洲专利局集中攻击攻击欧洲专利的机会。

我们的欧洲专利律师在欧洲专利局(EPO)的异议部和各种上诉委员会都有丰富的经验。

View 欧洲专利异议和上诉

经验

Promptu Systems Corporation v. Comcast Corporation

Obtained a $240 million jury verdict for client Promptu in a patent infringement lawsuit against Comcast. The jury found that Comcast willfully infringed Promptu’s patents covering voice recognition technology for TV.

2:16-cv-06516, E.D. Pa., Judge Sanchez
22-1939, Fed. Cir., Judges Prost, Moore, Taranto

Carrum Technologies, LLC v. BMW of North America, LLC, et al.

Obtained complete victory against Carrum on appeal of the District of Delaware’s claim construction to the Federal Circuit following Carrum’s stipulation of non-infringement under the claim construction, thereby exonerating BMW’s ACC system, first sold in 2000, against Carrum’s 2004 patents. Invalidated several asserted claims through post-grant efforts before the U.S. Patent Office, including IPRs and EPRs, and pursued claims through proceedings before the Eastern District of Virginia to vindicate BMW’s patent challenges.

1:18-cv-01645, D. Del., Judge Andrews
21-1435, 24-1480, Fed. Cir., Judges Clevenger, Cunningham, Lourie, Moore, Prost, Taranto
IPR2019-00902, -00903, -00904, -00905, -00927, 00928, PTAB, Judges Browne, Scanlon, Tornquist
90/019,010, CRU

Eye Therapies, LLC v. Slayback Pharma, LLC

Finnegan represented Bausch & Lomb’s licensee Eye Therapies, LLC in an appeal at the U.S. Court of Appeals for the Federal Circuit from a Patent Trial and Appeal Board (PTAB) decision finding Eye Therapies’ patent directed to a low-dose brimonidine treatment for eye redness (Lumify®) to be unpatentable. In a precedential decision, the Federal Circuit agreed with Finnegan’s arguments and found that the Board had wrongly invalidated the patent based on an incorrect claim construction, vacating and remanding the case back to the PTAB. The proceeding settled shortly thereafter

23-2173, Fed. Cir., Judges Taranto, Stoll, Scarsi

US Synthetic Corporation (USS) v. International Trade Commission (ITC)

Secured a significant victory for client US Synthetic Corporation (USS) with a precedential decision from the U.S. Court of Appeals for the Federal Circuit (CAFC) overturning an unfavorable 35 U.S.C. § 101 eligibility ruling from the International Trade Commission (ITC).

23-1217, Fed. Cir., Judges Chen, Dyk, Stoll

BMW of North America, LLC and Bayerische Motoren Werke AG v. Arigna Technology Ltd.

Secured a covenant-not-to-sue and zero-dollar walkaway for BMW Group in a declaratory judgment action, concluding Arigna’s high-profile patent enforcement campaign involving current amplification technology. This outcome follows a decisive ITC victory, the dismissal of parallel District Court litigation, and multiple concurrent patent office challenges pending at the time of resolution.

1:23-cv-01190, D.D.C., Judge Contreras
2:21-cv-00173, E.D. Tex.
IPR2021-01531, PTAB, Judges Baer, Fenick, Iftikhar
23-1931, Fed. Cir.
90/019,261, USPTO

Incyte Corp. v. Concert Pharmaceuticals, Inc.

In a rare rehearing proceeding, successfully represented petitioner Incyte in an inter partes review (IPR) challenging the validity of Concert’s patent before the Patent Trial and Appeal Board (PTAB). Continued representation of appellee Incyte before the Federal Circuit and secured a unanimous affirmance of the PTAB’s obviousness determination.

IPR2017-01256, PTAB, Judges Fitzpatrick, Hulse, Yang, Smith, Franklin
19-2011, Fed. Cir., Judges Hughs, Linn, Stark

More

专业见解

Federal Circuit IP Blog

“2” Does Not Provide Written Description Support for “1”: Federal Circuit Affirms District Court’s Invalidation of Patent

July 8, 2026

Federal Circuit IP Blog

Federal Circuit Vacates and Remands Infringement and Damages Judgment After Erroneous Verdict Form and Eligibility Analysis

July 8, 2026

At the PTAB Blog

Federal Circuit PTAB Appeal Statistics for March–May 2026

July 2, 2026

Articles

Article_D.-Mass-Patent-Litigation-Update-October-2024

D. Mass. Patent Litigation Update: May 2026

June 30, 2026

Federal Circuit IP Blog

Federal Circuit Affirms Noninfringement Ruling in Hatch-Waxman Litigation Based on Claim Construction, Prosecution History Estoppel, and the Disclosure-Dedication Rule

June 26, 2026

Federal Circuit IP Blog

Mere Invalidity of Asserted Claims Does Not Render Patent Infringement Case Exceptional or Warrant Sanctions

June 26, 2026

More

近期活动

Conference

4th Global Patent Litigation FORUM

October 29, 2026

Munich

新闻

Award/Ranking

Forbes Names Finnegan Partner Erika Harmon Arner on its Inaugural 2026 America’s Top Women Lawyers List

June 5, 2026

Commentary

Justices to Side with Generic Drugmakers in Patent Spat, Attorneys Predict

May 5, 2026

Commentary

Supreme Court Takes Up Generic Drug Labeling Fight

April 29, 2026

Press Release

BMW AG Secures Complete Victory at Federal Circuit as Onesta IP, LLC Appeal is Dismissed and Costs Awarded to BMW

April 20, 2026

Award/Ranking

Finnegan Wins “Americas Firm of the Year” and “ITC Firm of the Year” at the 2026 Managing Intellectual Property Americas Awards

April 10, 2026

Media Mention

Fed. Circ. Chief Feels 'Bright-Line Rule Coming' for IP Marking

April 9, 2026

More

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • 隐私
  • 免责申明
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP